| 5hmC | 5-hydroxymethylcytosine | LTP | Long-term potentiation |
| 5mC | 5-methylcytosine | MBD | Methyl-CpG-binding domain |
| AD | Alzheimer’s disease | mCA | Methylated CA |
| ADK | Adenosine kinase | mCAC | Methylated CAC |
| ADO | Adenosine | mCG | Methylated CpG |
| ADORA2A | Adenosine A2a receptor | MCI | Mild cognitive impairment |
| AHCY | Adenosylhomocysteinase | Met | Methionine |
| ALS | Amyotrophic lateral sclerosis | mGluRI | Metabotropic glutamate receptor group I |
| AMP | Adenosine monophosphate | mHTT | Mutant HTT |
| ASD | Autism spectrum disorders | mQTL | Methylation quantitative trait locus |
| Aβ | Amyloid beta | MTs | Microtubules |
| C9orf72 | Chromosome 9 open reading frame 72 | NCI | No cognitive impairment; |
| D-loop | Displacement loop | NFT | Neurofibrillary tangles |
| DMRs | Differentially methylated regions | NPCs | Neural progenitor cells |
| DNAm | DNA methylation | NTD | N-terminal domain |
| DNMTs | DNA methyltransferases | PB | Peripheral blood |
| DRPs | Dipeptide repeat proteins | PBMCs | Peripheral blood mononuclear cells |
| FMRP | Fragile X mental retardation protein | PHFs | Paired helical filaments |
| FTD | Frontotemporal dementia | pHRE | Pathogenic hexanucleotide G4C2 repeats expansion |
| FXS | Fragile X syndrome | Pol II | RNA polymerase II |
| G4C2 | GGGGCC | p-tau | Phosphorylated-tau |
| GABA | Gamma-aminobutyric acid | RAN | Repeat-associated non-ATG translation |
| GoF | Gain of function | RBPs | RNA binding proteins |
| Hcy | Homocysteine | SAH | S-adenosyl homocysteine |
| HD | Huntington’s disease | SAM | S-adenosyl methionine |
| HTT | Huntingtin gene | SNCA | α-synuclein |
| ICIs | Intracytoplasmic inclusions | SNP | Single-nucleotide polymorphism |
| INIs | Intranuclear inclusions | SZ | Schizophrenia |
| LAS | Lysosomal autophagy system | TET | Ten-eleven translocation |
| lncRNAs | Long non-coding RNAs | TFs | Transcription factors |
| LoF | Loss of function | TRD | Transcriptional repression domain |
| LTD | Long-term depression |